For people with atopic dermatitis, what goes on the skin matters enormously. A well-designed skincare routine supports barrier repair, reduces flare frequency, and minimizes dependence on prescription medications. A poorly chosen routine, wrong cleansers, fragranced products, over-washing, actively worsens the condition.
Step 1: Cleansing
What to use: A fragrance-free, soap-free, pH-balanced cleanser (syndets or non-soap bars). Avoid traditional soaps, which have a high pH (9–10) that disrupts the skin’s acid mantle and removes essential lipids.
How to wash: Lukewarm water, never hot. Hot water strips skin lipids and vasodilates, worsening itch. Limit shower or bath time to 5–10 minutes.
What to avoid: Physical exfoliation, washcloths, or loofahs on eczema-affected areas, the mechanical friction damages an already-compromised barrier.
Step 2: Moisturizing (Within 3 Minutes)
The “soak and seal” technique is evidence-based and highly effective: 1. Pat skin gently dry with a soft towel, do not rub 2. Apply prescribed topical medications to affected areas 3. Apply moisturizer generously over the entire body within 3 minutes, while the skin retains bath moisture
Moisturizer selection: Thick creams and ointments (containing ceramides, petrolatum, dimethicone) are far more effective than thin lotions. Ointments (Vaseline, Aquaphor) provide the strongest barrier protection. Fragrance-free is essential, fragrance is one of the most common contact sensitizers in eczema patients.
Step 3: Avoiding Triggers in Your Routine
- Fragrance, in cleansers, shampoos, laundry detergents, and fabric softeners
- Preservatives, methylisothiazolinone (MI) and methylchloroisothiazolinone (MCI) are common sensitizers; check labels
- Wool fabric next to the skin, irritating even without an allergy
- Overheating, wearing too many layers increases sweating and itch
Frequency and Quantity
For eczema patients, moisturizer should be applied at least twice daily, after bathing and before bed. Use more than you think you need. Studies show most patients apply one-tenth of the amount needed for effective barrier support.
NuLine’s atopic dermatitis clinical trials may offer access to treatments that reduce the burden of daily management.